title: [Drug therapy of ulcerative colitis].
abstract: The lethality of the severe ulcerative colitis has been markedly reduced in the last decades by drug and surgical therapy. The activity and extent of the disease is of immense importance for the drug therapy. In the last 30-40 years numerous controlled clinical trials provided treatment options for the active ulcerative colitis and maintenance of remission. This paper should give a short overview of the standard therapy.
authors.affiliation: Medizinische Poliklinik/Ambulante Spezialmedizin, Charité, Humboldt-Universität zu Berlin.
authors.forename: Y
authors.initials: Y
authors.lastname: Rückert
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects; D000636:Aminosalicylic Acids / Q000008:administration & dosage / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D019804:Mesalamine; D012460:Sulfasalazine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000305:Adrenal Cortex Hormones; D000636:Aminosalicylic Acids; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D012460:Sulfasalazine; D019804:Mesalamine
vernacular_title: Medikamentöse Therapie der Colitis ulcerosa.